Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 11, 2015 - Issue
Submit an article Journal homepage
45
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis

Michele Jara1 Drug Safety and Risk Management, Acorda Therapeutics, Inc, Ardsley, NY, USACorrespondence[email protected]
,
Matthew F Sidovar2 Clinical Development and Medical Affairs, Acorda Therapeutics, Inc, Ardsley, NY, USA
&
Herbert R Henney III2 Clinical Development and Medical Affairs, Acorda Therapeutics, Inc, Ardsley, NY, USA
Pages 1-7 | Published online: 16 Dec 2014

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michele Jara, Thomas Aquilina, Peter Aupperle & Adrian L Rabinowicz. (2015) Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States. Drug, Healthcare and Patient Safety 7, pages 169-174.
Read now

Articles from other publishers (1)

Ali A. Asadi-Pooya, Mohamad Ali Sahraian, Farzad Sina, Seyed Mohammad Baghbanian, Jafar Mehvari Habibabadi, Vahid Shaygannejad, Marjan Asadollahi, Sanaz Ahmadi Karvigh, Abdorreza Naser Moghadasi, Alireza Nikseresht & Mahmoud Motamedi. (2019) Management of seizures in patients with multiple sclerosis; an Iranian consensus. Epilepsy & Behavior 96, pages 244-248.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.